Skip to main content Start main content

News

BOWL4108

PolyU RCMI, MCMIA and GP-TCM RA co-organise Forum on Global Regulatory Challenges in Herbal Drug Innovation

[Hong Kong, 10 November 2026] The PolyU Research Centre for Chinese Medicine Innovation (RCMI), the Modernized Chinese Medicine International Association (MCMIA) and the Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA) successfully co-hosted the University-Industry Collaboration Forum: Navigating Global Regulations to Accelerate Herbal Drug Innovation at The Hong Kong Polytechnic University (PolyU). The Forum brought together leading academics, industry experts, and regulatory officials to explore strategies for overcoming regulatory barriers and advancing innovation in the global herbal medicine sector. Nearly 100 participants attended in person or online, underscoring the significance and timeliness of the theme.   Distinguished speakers including Prof. Dennis CHANG, Director and Professor of Pharmacology of the NICM Health Research Institute, Western Sydney University, Australia; Prof. Rudolf BAUER, Professor Emeritus of the University of Graz, Austria; Dr. MA Yuan-Chun, CEO and Chairman of the Dr. Ma’s Laboratories Inc., Canada; and Prof. LIU Jianping, Director of the Center for Evidence-Based Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, China. They shared the latest developments in herbal pharmacology, standardisation, and regulatory compliance, shedding light on ways to align scientific research with international safety and efficacy standards.   A highlight of the event was the panel discussion featuring prominent leaders from both the clinical and commercial sectors: Prof. Bernard M. Y. CHEUNG, Chief Executive Officer of the Greater Bay Area International Clinical Trial Institute, HKSAR, China; Prof. Paul LI, Professor, Department of Chemistry of the Simon Fraser University, Canada; and Mr. Abraham CHAN, Founder, Chairman and CEO of the PuraPharm Corporation Limited, HKSAR, China.   The panellists engaged in a dynamic discussion on the pathways for translating laboratory research into market-ready products, highlighting the importance of the Greater Bay Area as a hub for clinical trials and the role of international partnerships in meeting global regulatory requirements.   Speaking at the Forum, Dr Vincent CHUNG Chi-ho, Commissioner for Chinese Medicine Development of the HKSAR Government, emphasised the need for cross-sector collaboration to accelerate the translation of research into real-world healthcare solutions. He said: “This Forum underscores our commitment to bridging the gap between academic research and industrial application. By navigating global regulations together, we can ensure that high-quality herbal innovations reach patients safely and efficiently.”   The Forum marked an important step towards strengthening collaboration across the herbal medicine ecosystem. Looking ahead, RCMI will continue to foster dialogue, partnerships and knowledge exchange to advance integrative medicine and natural product research. 【香港,2026年11月9日】香港理工大學(理大)中醫藥創新研究中心、現代中醫藥國際協會及中醫藥規範研究學會於理大合辦「產學研合作論壇:對接國際法規標準,加速草本藥物創新」。論壇匯聚學術界、業界及監管機構代表,共同探討應對法規挑戰的策略,推動全球草本藥物領域的創新發展。近 100 名參加者透過現場或線上方式參與,反映議題備受關注,切合業界當前需要。   論壇邀得多位國際知名專家擔任講者,包括澳洲西悉尼大學藥理學教授兼國家輔助醫學研究院院長張旭東教授、奧地利格拉茨大學榮休教授鲍儒德教授、加拿大馬氏實驗室行政總裁兼主席馬元春博士,以及成都中醫藥大學附屬醫院循證醫學中心主任劉建平教授。各講者分享草本藥理學、標準化及法規合規方面的最新進展,探討如何使科研成果符合國際安全及療效標準。   論壇的一大亮點為專題討論環節,邀得臨床及商界領袖参與: 粵港澳大灣區國際臨床試驗所行政總裁張文勇教授 加拿大西門菲莎大學化學系教授李保華教授 香港培力控股有限公司創辦人、主席兼行政總裁陳宇齡先生   嘉賓深入探討將實驗室研究成果轉化為市場產品的路徑,並強調粵港澳大灣區作為臨床試驗樞紐的重要地位,以及國際合作在符合全球監管要求方面的關鍵作用。   香港特別行政區政府中醫藥發展專員鍾志豪博士於論壇上致辭時,強調跨界別合作對加快科研成果轉化為實際醫療方案的重要性。他表示:「此次論壇彰顯了我們致力促進學術研究與產業應用對接的決心。透過共同應對全球法規要求,我們能夠確保優質的草本藥物創新成果以安全及高效的方式惠及患者。」   是次論壇為加強草本藥物領域的協作邁出重要一步。展望未來,理大中醫藥創新研究中心將繼續促進跨界別交流、夥伴合作及知識共享,推動整合醫學與天然產物研究的發展。    

6 Nov, 2026

WhatsApp Image 20261105 at 43104 PM

Delegation Visits Shenzhen Research Institute and Jinan University to Advance Collaboration on Herbal Medicine and Gut Microbiota

The Research Centre for Chinese Medicine Innovation (RCMI) is pleased to announce the successful completion of an academic delegation visit to the Greater Bay Area, aimed at strengthening research partnerships and exploring the intersection of traditional medicine and modern microbiome science. The delegation, led by RCMI Director Professor Wong Man-sau, departed on 4 November 2026 with a visit to the Shenzhen Research Institute. During this visit, the team held strategic discussions focused on identifying collaborative opportunities for future research projects in the region. On 5 November 2026, the team continued their engagements with a meeting at Jinan University. They were hosted by Professor Yao Xinsheng and his academic team. The highlight of the visit was a keynote presentation delivered by Professor Bauer, titled "The Relevance of Gut Microbiota for the Activity of Herbal Medicine". The presentation addressed current advancements in understanding how gut microbiota influences the efficacy of herbal therapies. The session facilitated robust academic exchange regarding the mechanistic pathways and potential clinical applications of this research field. Delegation Members: The delegation was led by Professor Wong Man-sau and included the following members: Professor Bauer Dr. MOK Dr. Timothy Tang Dr. Chen Sibao Both RCMI and Jinan University expressed their commitment to fostering long-term collaboration. The teams look forward to translating these initial discussions into concrete research partnerships and joint publications.

6 Nov, 2026

WhatsApp Image 20261025 at 22833 PM 4

RCMI Delegation Visits Ningbo University

A delegation from the Research Centre for Chinese Medicine Innovation (RCMI), PolyU, visited Ningbo University to attend its 40th Anniversary Celebration and the 30th Anniversary of the Tri-merger. Led by the Vice President (Research) Prof. Xiang-dong Li, the visit aimed to strengthen academic collaborations and explore future research opportunities between the two institutions. Strategic Partnership MoU Signed On 24 October 2026, as part of the anniversary celebrations, Prof. Li signed a Memorandum of Understanding (MoU) with Ningbo University. This agreement marks a significant step in fostering long-term cooperation in research, education, and talent development. Research Exchange at New Drug Technology Institute During the visit, the delegation visited the New Drug Technology Research Institute at Ningbo University. The team toured the laboratories and engaged in technical discussions regarding potential joint research projects in pharmaceutical innovation and medical technology. Dialogue Among Chinese and Foreign University Presidents A key highlight of the visit was the participation in the “Dialogue Among Chinese and Foreign University Presidents,” held as one of the main events of the anniversary. The dialogue centred on the theme: “New Horizons · New Governance: Reshaping the Role and Institutional Reform of Universities in the AI Era.” Prof. Li joined roundtable forums to share insights on how artificial intelligence is influencing higher education governance, curriculum development, and research methodologies. The discussion emphasized the need for institutional reform to adapt to the rapid advancements in AI technology. Commitment to High-Quality Development The delegation also attended the High-Quality Development Conference, where leaders from across the region discussed strategies for sustainable growth in the academic sector. The RCMI team expressed strong support for the partnership and looks forward to implementing the agreed-upon collaborative initiatives in the coming months.

26 Oct, 2026

DSC09123

Strengthening School and Regional Cooperation

The Research Centre for Chinese Medicine Innovation (RCMI), The Hong Kong Polytechnic University, welcomed a delegation from the Garze Tibetan Autonomous Prefecture, Sichuan Province, on 15 October 2026. The visit aimed to explore opportunities for school-local cooperation and regional development. High-Level Visit The Garze delegation was led by Ms. Xie Hongxia, Deputy Secretary-General of the People's Government of Garze Tibetan Autonomous Prefecture. On the RCMI side, Administrative Director Dr. Daniel Mok and RCMI Member Dr. Zhang Huan hosted the visit and facilitated the discussions. During the meeting, Dr. Mok delivered a comprehensive presentation introducing RCMI’s research mission, facilities, and ongoing projects. This provided the delegation with a clear understanding of the Centre’s capabilities in medical innovation and interdisciplinary research. Strategic Focus Areas The discussion focused on learning from advanced experiences in education management, talent training, and technology transfer. Both parties identified three key areas for potential collaboration: Tibetan-Chinese Medicine Integration: Leveraging academic research to support the development of traditional medicine. Cultural and Tourism Innovation: Applying research insights to enhance industry growth. Sichuan-HK Cultural Exchange: Strengthening people-to-people bonds between the two regions. Commitment to Mutual Benefit The visit concluded with a strong commitment to exploring normalized school-local cooperation models. The parties agreed to work towards a framework that ensures complementary advantages and mutual benefit for both the university and the prefecture. RCMI looks forward to implementing these collaborative initiatives to drive innovation and regional development.

22 Oct, 2026

Screenshot 2026-09-23 164603

8th Greater Bay Area Traditional Chinese Medicine Conference

Prof. Simon Lee, Management committee member of RCMI represented RCMI at the 8th Greater Bay Area Traditional Chinese Medicine (TCM) Inheritance, Innovation, and Development Conference, held in Macau on September 22, 2026. Prof. Lee participated in a high-level signing ceremony with Dr. Huang, representing the Affiliated Integrated Chinese and Western Medicine Hospital of Guangdong Pharmaceutical University (Zhongshan Chen Xinghai Integrated Chinese and Western Medicine Hospital). The Memorandum of Understanding (MOU) establishes a strategic partnership to advance collaborative basic and clinical research in Traditional Chinese Medicine. Key Focus Areas of Collaboration The partnership will concentrate on the scientific evaluation and therapeutic application of TCM in the following fields: Musculoskeletal disorders Stroke rehabilitation Neuroprotection Sleep and mood disorders Tumor treatment A primary objective of this collaboration is to jointly apply for the 8th Guangdong-Hong Kong-Macao Greater Bay Area Traditional Chinese Medicine Inheritance, Innovation, and Development Conference Collaborative Project. The conference also featured specialized sub-forums dedicated to TCM and Chinese Medicine. These sessions brought together leading experts and scholars from Guangdong, Hong Kong, and Macau to share the latest research findings and clinical practice experiences. The event underscored a shared commitment to promoting resource sharing and synergistic innovation across the Greater Bay Area. Prof. Lee expressed optimism about the future prospects of this partnership, noting that it marks a significant step toward enhancing cross-border healthcare solutions and strengthening TCM research capabilities in the region.

23 Sep, 2026

Weixin Image_20260827140125_368

Unlocking the Science of Tradition with Prof. Lijia Xu

We are thrilled to have successfully concluded our seminar on "Innovative Applications of Medicinal Plant Taxonomy Theory in the Basic Research of Medicine-and-Food Homologous Substances," featuring the distinguished Prof. Lijia Xu. Prof. Xu, Director of the Research Center for Medicinal Plant Taxonomy at the Institute of Materia Medica (CAMS & PUMC), took us on a fascinating journey through the intersection of ancient wisdom and modern science. Key Highlights from the Session: 🔬 Bridging Theory & Practice: Prof. Xu demonstrated how medicinal plant taxonomy provides a rigorous scientific framework for validating "Medicine-Food Homology" (药食同源). ☕ Decoding Traditional Teas: We explored groundbreaking research revealing the scientific mechanisms behind how specific folk traditional teas can delay aging and prevent chronic diseases. 🏆 A Legacy of Innovation: As an award-winning researcher (First Prize of Science and Technology, China Association of Chinese Medicine) and author of over 100 papers, Prof. Xu shared insights from his extensive work on the material basis of plant-based health solutions. A massive thank you to Prof. Xu for sharing his visionary research and to everyone who attended. The discussion on how taxonomy can revolutionize the future of preventive medicine and functional foods was truly inspiring. Stay tuned for more updates from our research community!

27 Aug, 2026

Screenshot 2026-08-14 165133

RCMI Leaders Strengthen Global Pathways for TCM at International Conference on Modernization of Chinese Medicine at ICMCM 2026

We are thrilled to announce that the Research Centre for Chinese Medicine Innovation (RCMI) at The Hong Kong Polytechnic University (PolyU) played a pivotal role in the International Conference on the Modernization of Chinese Medicine & Health Products, held from August 13–15, 2026. This landmark event convened global experts to shape the future of Clinical Translation, Regulatory Policies, and Innovative Pathways for Traditional Medicine. 🤝 Representing PolyU On August 13, Dr. Mok, Associate Director of RCMI, attended the opening ceremony and key plenary sessions as a distinguished guest. Her participation underscored RCMI's unwavering dedication to fostering global collaboration and advancing the standards of Chinese medicine. 🎙️ Shaping the Global Dialogue The highlight of our delegation was Session 3 on August 14. Prof. Wong Man-sau, Director of RCMI, served as Co-Moderator for the high-level panel: "Traditional Medicine / Chinese Medical Development and Clinical Research" (傳統醫學/中醫科研發展與臨床研究). Standing alongside Prof. Feng Yibin (Co-Director, HKUMed Centre of Integrative Medicine, HKU), Prof. Wong led insightful discussions on strategies to elevate evidence-based TCM on the global stage. Her leadership facilitated critical conversations on bridging traditional wisdom with modern scientific rigor. We are incredibly proud of our team for contributing to the future of this vital field! 

17 Aug, 2026

IMG_20260804_155439

RCMI and Shanghai Yueyang Hospital Forge Strategic Alliance in Integrative Medicine

In a significant step forward for global healthcare collaboration, the Research Center for Chinese Medicine Innovation (RCMI) and the Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Hospital of Integrated Traditional Chinese and Western Medicine (hereinafter "Yueyang Hospital") officially signed a Memorandum of Understanding (MoU) on August 4, 2026. The ceremony was held at the state-of-the-art facilities of the PolyU Shenzhen Research Institute (SZRI), bringing together delegations from both prestigious institutions to formalize a partnership dedicated to advancing the frontiers of Traditional Chinese Medicine (TCM) and Western medical integration. Key Collaboration Scope: Joint R&D: Focused on kidney diseases, dermatological external drugs, tumor immunology, gynecology, organ anti-aging, and medicine-food homology. Talent & Education: Joint student training, faculty exchanges, and regular academic symposiums. Resource Integration: Shared access to clinical databases, literature, and research facilities.   Prof. Lee signed the MoU on behalf of RCMI.This alliance underscores SZRI's commitment to serving as a hub for international medical innovation. As both institutions move forward, the partnership aims to develop new treatment protocols for complex chronic diseases and share findings with the global medical community. With this MoU in place, RCMI and Yueyang Hospital are poised to lead the next wave of breakthroughs in integrative medicine, ensuring that the wisdom of tradition meets the precision of modern science.  

5 Aug, 2026

758543390_1798297084940088_641563162827136989_n

Dr. Poon Showcases Team Breakthroughs at CGCM 2026 in Taichung

RCMI members- Dr. Poon successfully presented our latest findings at the CGCM 2026 conference, held from July 25–27 in Taichung, Taiwan. It was a privilege to showcase our team's work in two distinct formats: a detailed poster session that facilitated a deep dive into our data and methodology, and an oral presentation where Dr. Poon shared key insights and future directions with the global scientific community. The conference provided an incredible opportunity to connect with fellow researchers, exchange ideas, and discuss the future of our field. We extend our sincere gratitude to everyone who stopped by our booth to engage, ask questions, and share their insights. These valuable conversations have further strengthened our network and will undoubtedly continue to drive our research forward.

3 Aug, 2026

Weixin Image_20260721092505

Advancing Integrative Medicine: Key Insights from the 14th GP‑TCM RA Annual Meeting

We are proud to share the success of the 14th Annual Meeting of the GP‑TCM Research Association (GP‑TCM RA), held July 7–9, 2026, at Nanyang Technological University (NTU), Singapore. Under the theme "Bridging East and West: Global Collaboration in Integrative Medicine," the event united global leaders to shape the future of Traditional Chinese Medicine (TCM). 🎤 Featured Presentations: Our team made significant contributions to the dialogue: Prof. Jerry Yeung (Associate Director of RCMI) delivered a pivotal talk on "Major Interventions in Clinical Practice Guidelines of Major Depressive Disorder," offering critical insights into evidence-based mental health care. Prof. Simon Ming Yuen Lee (RCMI Management Committee & GP‑TCM RA President‑Elect) presented on "Natural Products and Neuroprotection," highlighting the potential of TCM in protecting neurological health. Prof. Lee also emphasized the Association's commitment to strengthening international collaboration and advancing scientific rigor across the integrative medicine landscape. 🔬 Key Themes: The three-day agenda covered a vast spectrum of topics, including: ✅ Quality Control & Pharmacology ✅ Regulatory Science & Industry Perspectives ✅ Clinical Practice Guidelines ✅ Acupuncture-Moxibustion & Meridian Science ✅ Translational Research & Scientific Publishing Through poster sessions, networking, and an awards ceremony, participants forged new partnerships and reaffirmed the need for harmonized standards to drive the modernization of TCM globally. A huge thank you to all speakers, attendees, and partners for making this event a resounding success!

20 Jul, 2026

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here